VolitionRX's EBIT per Share for the
three
months ended in Mar. 2024 was $-0.10.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.46.
During the past 3 years, the average EBIT per Share Growth Rate was -3.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -1.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -2.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for VolitionRX's EBIT per Share or its related term are showing as below:
VNRX'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -316 Med: -2.05 Max: 25.6
Current: -3.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of VolitionRX was 25.60% per year. The lowest was -316.00% per year. And the median was -2.05% per year.
VNRX's 3-Year EBIT Growth Rate is ranked worse than 54.86% of 175
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.7
vs VNRX: -3.30
VolitionRX's EBIT for the
three
months ended in Mar. 2024 was $-8.40 Mil.
VolitionRX EBIT per Share Historical Data
The historical data trend for VolitionRX's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VolitionRX (AMEX:VNRX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
VolitionRX EBIT per Share Related Terms
Thank you for viewing the detailed overview of VolitionRX's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VNRX has been successfully added to your 